Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 5 January 2026 - 6 January 2026

Rocket Lab Corporation stock rises after Cantor reiteration as investors track Neutron and Space Force work

Rocket Lab Corporation stock rises after Cantor reiteration as investors track Neutron and Space Force work

Rocket Lab shares closed at $78.15, up 2.8%, before slipping 0.7% after hours. The stock remains near a 52-week high after a December $816 million U.S. defense satellite contract win. Cantor Fitzgerald reiterated an Overweight rating and $72 price target. Investors await updates at Needham’s Growth Conference on Jan. 13–14.
6 January 2026
·····
JPMorgan stock hits record intraday high, crosses $900 billion value as banks lead Wall Street rally

JPMorgan stock hits record intraday high, crosses $900 billion value as banks lead Wall Street rally

JPMorgan shares jumped 2.6% to $334.04 Monday, lifting its market value above $900 billion after the bank launched a new advisory unit for top clients. Barclays raised its price target on the stock to $391. The S&P 500 financials index gained 2.2% as investors positioned for upcoming bank earnings and Friday’s U.S. jobs report. JPMorgan’s next results are due Jan. 13.
6 January 2026
·
Lam Research stock (LRCX) jumps 5% as CES 2026 AI headlines fuel chip-equipment rally

Lam Research stock (LRCX) jumps 5% as CES 2026 AI headlines fuel chip-equipment rally

Lam Research closed up 5.3% at $194.76 Monday, holding gains after hours as chip-equipment stocks rallied sharply. Applied Materials, KLA, and ASML each rose over 5%, outpacing the semiconductor ETF. Investors tracked CES news and awaited Lam’s Jan. 28 earnings report. Foxconn reported record Q4 revenue on strong AI product demand.
6 January 2026
···
Goldman Sachs stock jumps after Industry Ventures deal closes; Barclays lifts target ahead of earnings

Goldman Sachs stock jumps after Industry Ventures deal closes; Barclays lifts target ahead of earnings

Goldman Sachs shares climbed 3.8% after hours to $948.44 following news it closed its acquisition of Industry Ventures. Barclays raised its Goldman price target to $1,048 from $850, maintaining an Overweight rating. The S&P 500 financials index rose 2.2% Monday, with major banks hitting record highs. Goldman reports fourth-quarter results on Jan. 15.
6 January 2026
··
Exxon stock rises after-hours on Venezuela oil pivot; what XOM investors watch next

Exxon stock rises after-hours on Venezuela oil pivot; what XOM investors watch next

Exxon shares rose 2.2% to $125.36 in after-hours trading Monday after President Trump announced U.S. plans to take control of Venezuela and pursue its oil reserves. J.P. Morgan analysts estimate Exxon’s Venezuela arbitration damages at about $2 billion. Chevron gained over 5% in extended trading. Industry meetings in Washington and Exxon’s Jan. 7 filing are expected next.
6 January 2026
·
Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. market and revives price pressure fears

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. market and revives price pressure fears

Eli Lilly shares fell 3.6% to $1,041.51 in after-hours trading Monday after Novo Nordisk launched a pill version of its Wegovy weight-loss drug in the U.S. Novo’s shares rose 5.2% as investors reacted to new pricing and distribution details. Lilly’s stock traded as low as $1,034 earlier in the session. Investors await commentary at the J.P. Morgan Healthcare Conference and Lilly’s earnings call.
6 January 2026
···
Intel stock whipsaws ahead of CES Panther Lake debut as 18A chipmaking bet comes due

Intel stock whipsaws ahead of CES Panther Lake debut as 18A chipmaking bet comes due

Intel closed down 0.03% at $39.37 after a volatile session ahead of its CES update on the Panther Lake chip, the first high-volume product on its 18A process. Melius Research upgraded the stock to “buy” with a $50 target. Shares traded heavily, opening at $41.68 and hitting a low of $39.28 before settling near flat. Investors await details on manufacturing progress at the company’s 6 p.m. ET CES event.
6 January 2026
···
Why Strategy Inc stock is jumping after-hours: fresh Bitcoin buy, $17.44B Q4 paper loss

Why Strategy Inc stock is jumping after-hours: fresh Bitcoin buy, $17.44B Q4 paper loss

Strategy Inc. said it bought $116 million in bitcoin in the first four days of 2026, raising holdings to 673,783 coins. A regulatory filing showed a $17.44 billion fourth-quarter unrealized loss on digital assets. Shares rose 4.8% in after-hours trading as bitcoin climbed 3.4%. The company funded the latest purchase by selling 735,000 shares for $116.3 million.
5 January 2026
··
Bitcoin price jumps above $94,000 as Coinbase stock rallies; payrolls report is next test

Bitcoin price jumps above $94,000 as Coinbase stock rallies; payrolls report is next test

Bitcoin surged 3.3% to $94,191 late Monday after the U.S. said it struck Venezuela and captured President Nicolás Maduro. U.S. stocks closed higher, with the Dow at a record and crypto-linked shares rallying. Coinbase gained 7.8% after a Goldman Sachs upgrade. Traders await Friday’s U.S. jobs report and the Fed’s Jan. 27-28 meeting.
5 January 2026
·····
Silver price stock SLV jumps 5% as Venezuela strikes lift bullion; payrolls next

Silver price stock SLV jumps 5% as Venezuela strikes lift bullion; payrolls next

iShares Silver Trust (SLV) jumped 5.1% to $69.08 Monday, tracking a 5.2% surge in spot silver after U.S. strikes in Venezuela boosted safe-haven demand. SLV traded as high as $70.60, with over 100 million shares exchanged. Silver rose 147% in 2025 amid supply deficits and its U.S. critical mineral status. Traders await Friday’s U.S. jobs report for the next market move.
5 January 2026
····
1 … 469 470 471 472 473 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop